Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

被引:414
作者
Mow, WS
Vasiliauskas, EA
Lin, YC
Fleshner, PR
Papadakis, KA
Taylor, KD
Landers, CJ
Abreu-Martin, MT
Rotter, JI
Yang, HY
Targan, SR
机构
[1] Div Gastroenterol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA
[3] Steven Spielberg Pediat Res Ctr, Dept Pediat, Ctr Med Genet Birth Defects, Los Angeles, CA USA
关键词
D O I
10.1053/j.gastro.2003.11.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Crohn's disease patients can be characterized by antibody responses against Crohn's disease-related bacterial sequence, Escherichia coli outer membrane porin C, Saccharomyces cerevisiae (oilgomannan), and neutrophil nuclear antigens. Our aim was to determine whether expression of antibodies against Crohn's disease-related bacterial sequence and Escherichia coli outer membrane porin C is associated with distinct phenotypic manifestations. Methods: Sera from 303 patients were tested for antibodies to the Crohn's disease-related bacterial sequence (12), anti-Escherichia coli outer membrane porin C, anti-Saccharomyces cerevisiae, and perinuclear antineutrophil cytoplasmic antibodies and for 3 Crohn's disease-associated variants of the NOD2 gene (R702W, G908R, and 1007fs) and compared with clinical data. Results: Patients expressing 12 were more likely to have fibrostenosing Crohn's disease (64.4% vs. 40.7%; P < 0.001) and to require small bowel surgery (62.2% vs. 37.4%; P < 0.001). Patients with anti-Escherichia coli outer membrane porin C were more likely to have internal perforating disease (50.0% vs. 30.7%; P = 0.001) and to require small bowel surgery (61.4% vs. 44.2%; P = 0.003). Anti-Crohn's disease-related bacterial sequence was independently associated with fibrostenosis (P = 0.027) and small bowel surgery (P = 0.01), whereas anti-Escherichia coli outer membrane porin C was independently associated with internal perforations (P < 0.006). Patients positive for 12, anti-Escherichia coli outer membrane porin C, and anti-Saccharomyces cerevisiae were the most likely to have undergone small bowel surgery (72.0%; odds ratio, 8.6; P < 0.001) compared with patients without reactivity (23.0%). When the presence and magnitude of antibody responses were considered, 90% of patients with small bowel disease who required surgery had high levels of 12, Escherichia coli outer membrane porin C, and oligomannan antibodies, compared with only 18.2% with low-titer responses (P < 0.001). Conclusions: 12 and anti-Escherichia coli outer membrane porin C are associated with Crohn's disease phenotypes, and patients with the highest level of serum reactivity toward an increasing number of microbiota have the greatest frequency of strictures, internal perforations, and small bowel surgery.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 43 条
[1]   Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[3]   Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis:: A GISC study [J].
Annese, V ;
Andreoli, A ;
Andriulli, A ;
D'Inca, R ;
Gionchetti, P ;
Latiano, A ;
Lombardi, G ;
Piepoli, A ;
Poulain, D ;
Sendid, B ;
Colombel, JF .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08) :2407-2412
[4]   Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences [J].
Bayless, TM ;
Tokayer, AZ ;
Polito, JM ;
Quaskey, SA ;
Mellits, ED ;
Harris, ML .
GASTROENTEROLOGY, 1996, 111 (03) :573-579
[5]   Animal models of mucosal inflammation and their relation to human inflammatory bowel disease [J].
Blumberg, RS ;
Saubermann, LJ ;
Strober, W .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :648-656
[6]  
Brandwein SL, 1997, J IMMUNOL, V159, P44
[7]   Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12 [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2173-2182
[8]   Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6112-6119
[9]   CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864
[10]   The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874